Oxford, England, 5th October 2020.
PharmaVentures Ltd (“PharmaVentures”) is pleased to announce that it was the corporate finance advisor to Novartis on the divestment of its manufacturing facility in Barberà del Vallès, Spain, to Siegfried Holding AG, a global contract development and manufacturing organisation (CDMO).
